Skip to main content
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. — Investor Relations & Filings

Ticker · TPST ISIN · US69014Q1013 US Professional, scientific and technical activities
Filings indexed 986 across all filing types
Latest filing 2013-11-13 Interim / Quarterly Rep…
Country US United States of America
Listing US TPST

About Tempest Therapeutics, Inc.

https://www.tempesttx.com/

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2013
2013-11-13 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 13, 2013, reporting the financial results for the quarter ended September 30, 2013. It specifically mentions Item 2.02, which is "Results of Operations and Financial Condition," and includes a press release as Exhibit 99.1 announcing the third quarter fiscal 2013 financial results. The document length is 3450 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or analysis. According to the rules, initial announcements of quarterly financial results (key highlights only) are classified as Earnings Release (ER). This document fits the description of an Earnings Release rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K). Therefore, the correct classification is ER with high confidence.
2013-11-13 English
4
Director's Dealing
2013-10-01 English
4
Director's Dealing
2013-09-13 English
4
Director's Dealing
2013-09-13 English
3
Director's Dealing
2013-09-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.